[Changes of Serum Complement C1q in Patients with Multiple Myeloma].

Objective: To analyze the change of serum C1q in the course of multiple myeloma (MM) and its correlation with clinical characteristics.

Methods: A total of 138 newly diagnosed MM patients in Zhongnan Hospital of Wuhan University from June 2016 to December 2019 were selected as research objects, during the same period 50 age-matched anemia patients, 50 lymphoma patients, 50 leukemia patients, and 50 myelodysplastic syndrome (MDS) patients were selected as control groups. All the patients met WHO disease classification, and were definitely diagnosed by pathology or bone marrow smear/biopsy.